These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33206758)
1. Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era. Shi T; Wang H; Xie M; Li X; Zhu L; Ye X Clinics (Sao Paulo); 2020; 75():e2011. PubMed ID: 33206758 [TBL] [Abstract][Full Text] [Related]
2. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation. Tachibana T; Najima Y; Akahoshi Y; Hirabayashi S; Harada K; Doki N; Uchida N; Fukuda T; Sawa M; Ogata M; Takada S; Tanaka M; Matsuhashi Y; Tanaka J; Onizuka M; Ichinohe T; Atsuta Y; Kako S; Ann Hematol; 2020 Oct; 99(10):2393-2404. PubMed ID: 32803312 [TBL] [Abstract][Full Text] [Related]
3. [Effect of Philadelphia Chromosome Karyotype and Allogeneic Hematopoietic Stem Cell Transplantation on Patients with Acute Lymphoblastic Leukemia]. Wang Y; Xu XM; Zhang M; Wang H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1397-1406. PubMed ID: 36208241 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in complete remission in the era of tyrosine kinase inhibitors]. Cao XY; Ma W; Zhang W; Liu DY; Zhao YL; Lu Y; Zhang JP; Zhou JR; Xiong M; Wei ZJ; Sun RJ Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):564-569. PubMed ID: 32810963 [No Abstract] [Full Text] [Related]
5. Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant. Samra B; Kantarjian HM; Sasaki K; Alotaibi AS; Konopleva M; O'Brien S; Ferrajoli A; Garris R; Nunez CA; Kadia TM; Short NJ; Jabbour E Acta Haematol; 2021; 144(3):285-292. PubMed ID: 33238261 [TBL] [Abstract][Full Text] [Related]
6. T315I mutation exerts a dismal prognosis on adult BCR-ABL1-positive acute lymphoblastic leukemia, and salvage therapy with ponatinib or CAR-T cell and bridging to allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Ting S; Mixue X; Lixia Z; Xueying L; Wanzhuo X; Xiujin Y Ann Hematol; 2020 Apr; 99(4):829-834. PubMed ID: 32107574 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era. Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550 [TBL] [Abstract][Full Text] [Related]
8. Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study. Kim R; Chalandon Y; Rousselot P; Cayuela JM; Huguet F; Balsat M; Passet M; Chevallier P; Hicheri Y; Raffoux E; Leguay T; Chantepie S; Maury S; Hayette S; Solly F; Braun T; De Prijck B; Cacheux V; Salanoubat C; Farnault L; Guibaud I; Lamarque M; Gastaud L; Lemasle E; Brissot E; Tavernier E; Bilger K; Villate A; Soulier J; Graux C; Lhéritier V; Dombret H; Boissel N; Clappier E J Clin Oncol; 2024 Sep; 42(26):3140-3150. PubMed ID: 39028928 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia]. Liu Y; Mi RH; Chen L; Yuan FF; Yin QS; Fu YW; Zhu XH; Liu XJ; Zhang YL; Zhang WL; Wei XD Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):738-743. PubMed ID: 31648474 [No Abstract] [Full Text] [Related]
10. Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Xie M; Shi T; Jiang Q; Jia Y; Zhou D; Tong H; Jin J; Zhu HH Cancer; 2023 May; 129(10):1523-1536. PubMed ID: 36882308 [TBL] [Abstract][Full Text] [Related]
11. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy]. Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652 [TBL] [Abstract][Full Text] [Related]
12. The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation. Tachibana T; Kondo T; Uchida N; Doki N; Takada S; Takahashi S; Yano S; Mori T; Kohno A; Kimura T; Fukuda T; Atsuta Y; Nagamura-Inoue T; Transplant Cell Ther; 2022 Jun; 28(6):321.e1-321.e8. PubMed ID: 35296447 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779 [TBL] [Abstract][Full Text] [Related]
14. Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis. Zhang W; Kuang P; Liu T PLoS One; 2020; 15(12):e0243657. PubMed ID: 33338050 [TBL] [Abstract][Full Text] [Related]
15. Low-Level BCR::ABL1 Transcript at Diagnosis in Childhood Leukemia: A 10-Year Single Institution Study. Cain LE; Mirochnik O; Stevens MM; Kellie SJ; Padhye B; Keogh SJ; Govender D; Ryan J; Dalla-Pozza L; Bateman CM Genes Chromosomes Cancer; 2024 Sep; 63(9):e23269. PubMed ID: 39291932 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of Ph-positive acute lymphoblastic leukemia]. Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL]. Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417 [TBL] [Abstract][Full Text] [Related]
18. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612 [TBL] [Abstract][Full Text] [Related]
19. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
20. Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta-analysis. Zeng Q; Xiang B; Liu Z Cancer Med; 2021 Dec; 10(24):8741-8753. PubMed ID: 34761879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]